Mild Cognitive Impairment: Baseline and Longitudinal Structural MR Imaging Measures Improve Predictive Prognosis

References

• 1 Rafii MS, Aisen PS. Recent developments in Alzheimer’s disease therapeutics. BMC Med 2009;7:7.
  Medline Google Scholar
• 2 Cummings JL, Doody R, Clark C. Disease-modifying therapies for Alzheimer disease: challenges to early intervention. Neurology 2007;69(16):1622–1634.
  Medline Google Scholar
• 3 Aisen PS. Commentary on “a roadmap for the prevention of dementia II: Leon Thal Symposium 2008”—facilitating Alzheimer’s disease drug development in the United States. Alzheimers Dement 2009;5(2):125–127.
  Medline Google Scholar
• 4 Black RS, Sperling RA, Safirstein B, et al.. A single ascending dose study of bapineuzumab in patients with Alzheimer disease. Alzheimer Dis Assoc Disord 2010;24(2):198–203.
  Medline Google Scholar
• 5 McEvoy LK, Brewer JB. Quantitative structural MRI for early detection of Alzheimer’s disease. Expert Rev Neurother 2010;10(11):1675–1688.
  Medline Google Scholar
• 6 Petersen RC, Thomas RG, Grundman M, et al.. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005;352(23):2379–2388.
  Medline Google Scholar
• 7 Petersen RC, Aisen PS, Beckett LA, et al.. Alzheimer’s Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology 2010;74(3):201–209.
  Medline Google Scholar
• 8 Larrieu S, Letenneur L, Orgogozo JM, et al.. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology 2002;59(10):1594–1599.
  Medline Google Scholar
• 9 Jack CR, Petersen RC, Xu YC, et al.. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer’s disease. Neurology 1997;49(3):786–794.
  Medline Google Scholar
• 10 Dickerson BC, Feczko E, Augustinack JC, et al.. Differential effects of aging and Alzheimer’s disease on medial temporal lobe cortical thickness and surface area. Neurobiol Aging 2009;30(3):432–440.
  Medline Google Scholar
• 11 Fennema-Notestine C, Hagler DJ, McEvoy LK, et al.. Structural MRI biomarkers for preclinical and mild Alzheimer’s disease. Hum Brain Mapp 2009;30(10):3238–3253.
  Medline Google Scholar
• 12 Jack CR, Shiung MM, Weigand SD, et al.. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology 2005;65(8):1227–1231.
  Medline Google Scholar
• 13 Whitwell JL, Shiung MM, Przybelski SA, et al.. MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology 2008;70(7):512–520.
  Medline Google Scholar
• 14 Bakkour A, Morris JC, Dickerson BC. The cortical signature of prodromal AD: regional thinning predicts mild AD dementia. Neurology 2009;72(12):1048–1055.
  Medline Google Scholar
• 15 McEvoy LK, Fennema-Notestine C, Roddey JC, et al.. Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Radiology 2009;251(1):195–205.
  Medline Google Scholar
• 16 Vemuri P, Wiste HJ, Weigand SD, et al.. MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology 2009;73(4):294–301.
  Medline Google Scholar
• 17 Fox NC, Cousens S, Scahill R, Harvey RJ, Rossor MN. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. Arch Neurol 2000;57(3):339–344.
  Medline Google Scholar
• 18 Thompson PM, Hayashi KM, de Zubicaray G, et al.. Dynamics of gray matter loss in Alzheimer’s disease. J Neurosci 2003;23(3):994–1005.
  Medline Google Scholar
• 19 Holland D, Brewer JB, Hagler DJ, Fennema-Notestine C, Dale AM; Alzheimer’s Disease Neuroimaging Initiative. Subregional neuroanatomical change as a biomarker for Alzheimer’s disease. Proc Natl Acad Sci U S A 2009;106(49):20954–20959.
  Medline Google Scholar
• 20 McDonald CR, McEvoy LK, Gharapetian L, et al.. Regional rates of neocortical atrophy from normal aging to early Alzheimer disease. Neurology 2009;73(6):457–465.
  Medline Google Scholar
• 21 McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34(7):939–944.
  Medline Google Scholar
• 22 Jack CR, Bernstein MA, Fox NC, et al.. The Alzheimer’s Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 2008;27(4):685–691.
  Medline Google Scholar
• 23 Jovicich J, Czanner S, Greve D, et al.. Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage 2006;30(2):436–443.
  Medline Google Scholar
• 24 Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 1998;17(1):87–97.
  Medline Google Scholar
• 25 Fischl B, Salat DH, Busa E, et al.. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002;33(3):341–355.
  Medline Google Scholar
• 26 Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 1999;9(2):179–194.
  Medline Google Scholar
• 27 Fischl B, Sereno MI, Dale AM. Cortical surface-based analysis. II. Inflation, flattening, and a surface-based coordinate system. Neuroimage 1999;9(2):195–207.
  Medline Google Scholar
• 28 Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A 2000;97(20):11050–11055.
  Medline Google Scholar
• 29 Fischl B, van der Kouwe A, Destrieux C, et al.. Automatically parcellating the human cerebral cortex. Cereb Cortex 2004;14(1):11–22.
  Medline Google Scholar
• 30 Desikan RS, Ségonne F, Fischl B, et al.. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006;31(3):968–980.
  Medline Google Scholar
• 31 Buckner RL, Head D, Parker J, et al.. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume. Neuroimage 2004;23(2):724–738.
  Medline Google Scholar
• 32 Thompson WK, Holland D. Bias in tensor based morphometry stat-ROI measures may result in unrealistic power estimates. Neuroimage (in press).
  Google Scholar
• 33 Duda RO, Hart PE, Strok DG. Pattern classification. New York, NY: Wiley, 2000.
  Google Scholar
• 34 Davatzikos C, Fan Y, Wu X, Shen D, Resnick SM. Detection of prodromal Alzheimer’s disease via pattern classification of magnetic resonance imaging. Neurobiol Aging 2008;29(4):514–523.
  Medline Google Scholar
• 35 Fan Y, Batmanghelich N, Clark CM, Davatzikos C; Alzheimer’s Disease Neuroimaging Initiative. Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline. Neuroimage 2008;39(4):1731–1743.
  Medline Google Scholar
• 36 Klöppel S, Stonnington CM, Chu C, et al.. Automatic classification of MR scans in Alzheimer’s disease. Brain 2008;131(Pt 3):681–689.
  Medline Google Scholar
• 37 Vemuri P, Gunter JL, Senjem ML, et al.. Alzheimer’s disease diagnosis in individual subjects using structural MR images: validation studies. Neuroimage 2008;39(3):1186–1197.
  Medline Google Scholar
• 38 Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148(3):839–843.
  Google Scholar
• 39 Gu C. Smoothing spline ANOVA models. New York, NY: Springer-Verlag, 2002.
  Google Scholar
• 40 Pencina MJ, D’Agostino RB, D’Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27(2):157–172; discussion 207–212.
  Medline Google Scholar
• 41 Misra C, Fan Y, Davatzikos C. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. Neuroimage 2009;44(4):1415–1422.
  Medline Google Scholar
• 42 Rusinek H, De Santi S, Frid D, et al.. Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. Radiology 2003;229(3):691–696.
  Google Scholar
• 43 Risacher SL, Shen L, West JD, et al.. Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. Neurobiol Aging 2010;31(8):1401–1418.
  Medline Google Scholar
• 44 Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease: FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 2005;32(4):486–510.
  Medline Google Scholar
• 45 Herholz K, Carter SF, Jones M. Positron emission tomography imaging in dementia. Br J Radiol 2007;80(Spec No 2):S160–S167.
  Medline Google Scholar
• 46 Landau SM, Harvey D, Madison CM, et al.. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 2010;75(3):230–238.
  Medline Google Scholar
• 47 Karow DS, McEvoy LK, Fennema-Notestine C, et al.. Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease. Radiology 2010;256(3):932–942.
  Google Scholar
• 48 Villain N, Fouquet M, Baron JC, et al.. Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer’s disease. Brain 2010;133(11):3301–3314.
  Medline Google Scholar
• 49 Rabinovici GD, Jagust WJ. Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo. Behav Neurol 2009;21(1):117–128.
  Medline Google Scholar
• 50 Mattsson N, Zetterberg H, Hansson O, et al.. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 2009;302(4):385–393.
  Medline Google Scholar
• 51 Fjell AM, Walhovd KB, Fennema-Notestine C, et al.. CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer’s disease. J Neurosci 2010;30(6):2088–2101.
  Medline Google Scholar
• 52 Vemuri P, Wiste HJ, Weigand SD, et al.. MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations. Neurology 2009;73(4):287–293.
  Medline Google Scholar
• 53 Brewer JB. Fully-automated volumetric MRI with normative ranges: translation to clinical practice. Behav Neurol 2009;21(1):21–28.
  Medline Google Scholar